Search research articles
Contact Us
Filters
Showing results (251-260 of 945) with videos related to
Page
of 95
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1991
False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae
R N Jones, M E Erwin
Journal of Clinical Microbiology
|
December 1, 1991
Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin
R N Jones, M E Erwin
Postgraduate Medicine
|
August 12, 2009
Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999
M A Pfaller, R N Jones
Journal of Clinical Microbiology
|
March 1, 1990
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, R N Jones
The Journal of Antimicrobial Chemotherapy
|
April 1, 1996
In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates
M G Cormican, R N Jones
Journal of Clinical Microbiology
|
July 1, 1989
Comparison of cefadroxil and cephalothin disk susceptibility test results
A L Barry, R N Jones
Journal of Clinical Microbiology
|
October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillins
A L Barry, R N Jones
European Journal of Clinical Microbiology
|
April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test
A L Barry, R N Jones
Journal of Clinical Microbiology
|
November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)
R N Jones, A L Barry
Page
of 95
Search research articles
Search
Showing results (251-260 of 945) with videos related to
Sort By:
Page
of 95
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1991
False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae
R N Jones, M E Erwin
Journal of Clinical Microbiology
|
December 1, 1991
Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin
R N Jones, M E Erwin
Postgraduate Medicine
|
August 12, 2009
Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999
M A Pfaller, R N Jones
Journal of Clinical Microbiology
|
March 1, 1990
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, R N Jones
The Journal of Antimicrobial Chemotherapy
|
April 1, 1996
In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates
M G Cormican, R N Jones
Journal of Clinical Microbiology
|
July 1, 1989
Comparison of cefadroxil and cephalothin disk susceptibility test results
A L Barry, R N Jones
Journal of Clinical Microbiology
|
October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillins
A L Barry, R N Jones
European Journal of Clinical Microbiology
|
April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test
A L Barry, R N Jones
Journal of Clinical Microbiology
|
November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease
|
November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)
R N Jones, A L Barry
Page
of 95